ConductScience.org, home

Paper41007052

Choosing the "Ideal" Oral Dosage Form for Pediatric Patients: Parents' Perspectives on Children's Preferences with a Focus on Orodispersible Tablets.

Gvozdeva Y and 1 other. Children (Basel), 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Choosing the "Ideal" Oral Dosage Form for Pediatric Patients: Parents' Perspectives on Children's Preferences with a Focus on Orodispersible Tablets. Papers, record 41007052. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41007052

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Choosing the "Ideal" Oral Dosage Form for Pediatric Patients: Parents' Perspectives on Children's Preferences with a Focus on Orodispersible Tablets.
PubMed
Journal
Children (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-09-30
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gvozdeva YYanahttps://orcid.org/0000-0002-7622-6060
2Staynova RRadianahttps://orcid.org/0000-0002-8466-3236

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134822316Orodispersible tablets for pediatric drug delivery: current challenges and recent advances.Expert Opin Drug Deliv2021https://conductscience.org/library/papers/34822316PubMed
228040560A systematic review of the use of dosage form manipulation to obtain required doses to inform use of manipulation in paediatric practice.Int J Pharm2017https://conductscience.org/library/papers/28040560PubMed
334371705Accuracy of Dose Administered to Children Using Off-Labelled or Unlicensed Oral Dosage Forms.Pharmaceutics2021https://conductscience.org/library/papers/34371705PubMed
425854872Potentially harmful excipients in neonatal medicines: a pan-European observational study.Arch Dis Child2015https://conductscience.org/library/papers/25854872PubMed
522883696WHO guideline development of paediatric medicines: points to consider in pharmaceutical development.Int J Pharm2012https://conductscience.org/library/papers/22883696PubMed
635204916A Survey to Understand Parent/Caregiver and Children's Views on Devices Used for the Administration of Oral Pediatric Medicines in Japan.Children (Basel)2022https://conductscience.org/library/papers/35204916PubMed
727863675Age-appropriate and acceptable paediatric dosage forms: Insights into end-user perceptions, preferences and practices from the Children's Acceptability of Oral Formulations (CALF) Study.Int J Pharm2016https://conductscience.org/library/papers/27863675PubMed
825736528Orodispersible drug formulations for children and elderly.Eur J Pharm Sci2015https://conductscience.org/library/papers/25736528PubMed
938258129Potentially Harmful Excipients: State of the Art for Oral Liquid Forms Used in Neonatology and Pediatrics Units.Pharmaceutics2024https://conductscience.org/library/papers/38258129PubMed
1032992469Paediatric Formulation: Design and Development.Int J Mol Sci2020https://conductscience.org/library/papers/32992469PubMed
1124070789The STEP (Safety and Toxicity of Excipients for Paediatrics) database: part 2 - the pilot version.Int J Pharm2013https://conductscience.org/library/papers/24070789PubMed
1219149727Trends in pharmaceutical taste masking technologies: a patent review.Recent Pat Drug Deliv Formul2009https://conductscience.org/library/papers/19149727PubMed
1337689320Survey-based investigation into the current use of paediatric medicines and administration devices in China.Eur J Pharm Biopharm2023https://conductscience.org/library/papers/37689320PubMed
1428225679Pediatric Drug Formulations - Unintended Consequences of Legislation.N Engl J Med2017https://conductscience.org/library/papers/28225679PubMed
1530837807Adverse Drug Reactions in Children: Pediatric Pharmacy and Drug Safety.J Pediatr Pharmacol Ther2019https://conductscience.org/library/papers/30837807PubMed
1627270905Paediatric Drug Development and Formulation Design-a European Perspective.AAPS PharmSciTech2017https://conductscience.org/library/papers/27270905PubMed
1735056165Mini-Tablets: A Valid Strategy to Combine Efficacy and Safety in Pediatrics.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/35056165PubMed
1832265601Key Potentially Inappropriate Drugs in Pediatrics: The KIDs List.J Pediatr Pharmacol Ther2020https://conductscience.org/library/papers/32265601PubMed
1928250539Medicines for children: flexible solid oral formulations.Bull World Health Organ2017https://conductscience.org/library/papers/28250539PubMed
2031597277Innovations in Pediatric Drug Formulations and Administration Technologies for Low Resource Settings.Pharmaceutics2019https://conductscience.org/library/papers/31597277PubMed

See all 50 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41007052

GET https://conductscience.org/api/papers/v1/41007052/references?page=2